Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Docetaxel Every Three Weeks Best for Certain Metastatic Prostate Cancers
Link ID 2765
Title Docetaxel Every Three Weeks Best for Certain Metastatic Prostate Cancers
Url http://www.medscape.com/viewarticle/569356?src=rss
Description The survival of patients with hormone-resistant prostate cancer is significantly longer after treatment with docetaxel every 3 weeks with prednisone (D3P) compared with other regimens, according to the follow-up of a major study. Reuters Health Information
Category Articles > Pharmacists
Keywords
Date Jan 29, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Pharmacists
1. Fibromyalgia: New Insights Into a Misunderstood Condition
  This chronic disorder is often viewed with skepticism and uncertainty, but a growing body of evidence offers keys to diagnosis and treatment.
Medscape Pharmacists
Category:   Articles > Pharmacists


2. Shorter-Course Levofloxacin Therapy Suitable for Serious UTI
  A 5-day course of levofloxacin is at least as effective as a 10-day course of ciprofloxacin for treating acute pyelonephritis and complicated urinary tract infections (UTIs), note researchers from Ortho-McNeil Pharmaceuticals, which markets levofloxacin in the US as Levaquin. Reuters Health Information
Category:   Articles > Pharmacists


3. Chemotherapy and Tamoxifen Cut Long-Term Risk of Contralateral Breast Cancer
  Adjuvant chemotherapy and tamoxifen treatment for primary breast cancer are both independently associated with reduced risks of contralateral breast cancer that persist for up to 10 and 5 years, respectively, after the first cancer diagnosis, according to a report in the Journal of the National Cancer Institute for January 2. Reuters Health Information
Category:   Articles > Pharmacists


4. Raloxifene Reduces Risk of Endometrial Cancer
  While raloxifene and tamoxifen are broadly similar in reducing breast cancer risk, raloxifene also appears to lower the odds of developing endometrial cancer, researchers report in the September 1st issue of the Journal of Clinical Oncology. Reuters Health Information
Category:   Articles > Pharmacists


5. Warfarin Use Not Associated With Osteoporosis Risk in Men
  Warfarin use does not appear to increase the risk of osteoporosis in elderly men, according to a report in the July issue of the Journal of the American Geriatrics Society. Reuters Health Information
Category:   Articles > Pharmacists




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS